Mesmerize Marketing partners with IMS Research to provide prescription lift research for all DTC campaigns running on our network for at least 6 months.
Sample Research:
Mesmerize Marketing initiated a two-pronged program in August of 2010 meant to stimulate incremental Rx demand for King Pharmaceuticals’ Flector Patch
Positive Physician-Based Results
- Physicians Were Studied Against Similar “Controls”
- Physicians Generated A Significantly Positive Rx “Lift”
- Mesmerize Achieved This Result Even Though Most Test Physicians Had Little Flector Patch Rx Activity Before the Program Began
- The overarching goal of the program was to drive incremental Rx demand for the Flector Patch within the competitive pain market via tactics directed towards physicians
- Physicians were studied against like “controls”, with results showing significantly positive “lift” based on NRx volume and NRx market share
- Positive physician-based results are notable given that 2 out of 3 Mesmerize physicians had not written any Flector Patch Rx’s in the past year
- Positive program results were driven by low Flector Patch writers being motivated to increase their productivity
- Although low Flector Rx’ing status suggests competitive preferences, the Mesmerize program dislodged physicians enough from their habits to generate a positive (and statistically significant) Rx “lift” versus like controls
- “Lift” began a few months into implementation, which is common to programs directed towards low writers, who tend to require more ‘time to effect’ than their higher Rx’ing peers based upon IMS’ experience
